Bayesian Capital Management’s Doximity DOCS Stock Holding History

Bayesian Capital Management’s Portfolio DOCS Stock Details DOCS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-30,300	Closed	-$2.22M	–	238
2025 Q3	$2.22M	Buy	+30,300	New	+$1.98M	0.45%	60
2025 Q2	–	Sell	-43,800	Closed	-$2.54M	–	626
2025 Q1	$2.54M	Buy	43,800 +3,500	+9%	+$221K	0.42%	60
2024 Q4	$2.15M	Buy	+40,300	New	+$1.97M	0.26%	111
2024 Q3	–	Sell	-60,200	Closed	-$1.68M	–	768
2024 Q2	$1.68M	Buy	+60,200	New	+$1.59M	0.19%	141
2024 Q1	–	Sell	-120,900	Closed	-$3.39M	–	853
2023 Q4	$3.39M	Buy	+120,900	New	+$2.86M	0.36%	62
2023 Q3	–	Sell	-54,800	Closed	-$1.86M	–	766
2023 Q2	$1.86M	Buy	+54,800	New	+$1.82M	0.2%	139
2022 Q2	–	Sell	-39,000	Closed	-$2.03M	–	847
2022 Q1	$2.03M	Buy	+39,000	New	+$1.96M	0.3%	64

Other funds holding DOCS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bayesian Capital Management's DOCS Position: Q4 2025 in Review

Bayesian Capital Management sold out of Doximity (DOCS) in Q4 2025, closing a stake of 30,300 shares — an estimated $2.22M sold.

Bayesian Capital Management first reported a position in DOCS in Q1 2022 and held it in 7 quarters. The position peaked at $3.39M in Q4 2023. 470 funds tracked by Wall St. Rank hold DOCS as of Q4 2025.

Bayesian Capital Management reported no remaining Doximity position as of Q4 2025 after selling out during the quarter.
Bayesian Capital Management sold 30,300 Doximity shares in Q4 2025, an estimated $2.22M.
Bayesian Capital Management first reported a position in Doximity in Q1 2022 and held it in 7 quarters.
Bayesian Capital Management's Doximity position peaked at $3.39M in Q4 2023.
470 funds tracked by Wall St. Rank held Doximity as of Q4 2025.

Based on Bayesian Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.